| ADA: Linagliptin Works in Diabetic Kidney Disease - MedPage Today |
|
|
MedPage Today SAN DIEGO -- Type 2 diabetes patients with impaired renal function saw significant drops in HbA1c after treatment with linagliptin (Tradjenta) when compared with placebo, researchers said here. In a 12-week trial that enrolled patients with ... New data for linagliptin* to be presented at the ADA Canada NewsWire (press release) Linagliptin Bests Glimepiride in Reducing CV Risk Medscape New data for linagliptin* show clinically meaningful efficacy similar to |